Emerging Technologies

Why Ebola volunteers need praise, not stigma

Liisa Tuhkanen
Journalist, The Thomson Reuters Foundation

Volunteer medics returning to Britain after fighting the Ebola outbreak in West Africa face unfounded stigma that can be made worse by official safety guidelines, charities said on Tuesday.

“These people are putting their lives at risk and instead of being appreciated many of them are facing unfounded stigma on their return,” said Sarah Wilson, communication manager for Ebola response at World Vision.

“They should be lauded when they come back home not discouraged from volunteering.”

The guidelines, issued by Public Health England, include restrictions on the activities of returning medics, such as using public transport and returning to work.

“We are concerned that adding additional protocols for health workers to follow on their return to the UK could … contribute to the stigmatisation they face,” said John English, Ebola Response Programme Manager at the British Red Cross.

Professor Paul Cosford, director for health protection and medical director at PHE, said the restrictions were designed to reduce the possibility of returning volunteers developing Ebola symptoms in a situation where they cannot quickly get medical help.

“The principles behind this guidance are to ensure that returning workers have a reasonable degree of freedom for normal activities balanced against the need for them to be able to rapidly seek medical help should they develop any symptoms,” he said.

Guinea, Sierra Leone and Liberia have borne the brunt of the 20,000 infections and nearly 8,000 deaths since the current Ebola outbreak was first identified in remote southeast Guinea in early 2014.

British volunteers are among hundreds of foreign medics who have gone to the three countries to help local medical staff overwhelmed by the outbreak, the worst ever recorded.

Last week, British nurse Pauline Cafferkey, who had been working in Sierra Leone with Save the Children, became the first person to be diagnosed with the disease in Britain, shortly after her return from West Africa.

Travel restrictions were not relevant to Cafferkey’s case, Wilson said. “People are not contagious until they are too sick with the disease to get out of bed, let alone use public transportation,” she said.

Cafferkey, 39, is in a stable but critical condition at the Royal Free Hospital in London. She is being treated with blood plasma from an anonymous Ebola survivor and an experimental anti-viral drug.

Last year the hospital, Britain’s main centre for Ebola cases, successfully treated British nurse William Pooley with the experimental drug ZMapp after he became infected with the Ebola virus while working in Sierra Leone.


This article is published in collaboration with The Thomson Reuters Foundation. Publication does not imply endorsement of views by the World Economic Forum.

To keep up with Forum:Agenda subscribe to our weekly newsletter.

Author: Liisa Tuhkanen is a Journalist at The Thomson Reuters Foundation.

Image: Health workers put on protective gear before entering a quarantine zone at a Red Cross facility in the town of Koidu, Kono district in Eastern Sierra Leone December 19, 2014. Reuters//Baz Ratner.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Future of Global Health and Healthcare

Related topics:
Emerging TechnologiesGeographies in Depth
Share:
The Big Picture
Explore and monitor how Behavioural Sciences is affecting economies, industries and global issues
World Economic Forum logo

Forum Stories newsletter

Bringing you weekly curated insights and analysis on the global issues that matter.

Subscribe today

Deepfakes proved a different threat than expected. Here's how to defend against them

Nathan Hamiel

January 10, 2025

How GenAI delivers short-term wins and long-term transformation in an unpredictable world

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum